CombiMatrix Reiterates Previously Reported Terms of Nasdaq Listed Warrants (Symbol: CBMXW)
13 February 2014 - 6:30AM
Due to recent trading activity in CombiMatrix Corporation's
(Nasdaq:CBMX) publicly listed warrants, symbol CBMXW, the Company
would like to reiterate the terms of said warrants.
These warrants, originally issued in April 2009 and as adjusted
pursuant to their terms by the reverse split of the Company's
common stock and warrants previously announced on December 4, 2012,
currently have an exercise price of $90.00 and will expire on May
1, 2014 if not exercised by such time.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support for the highest
quality of care – specializing in miscarriage analysis, prenatal
and pediatric healthcare. CombiMatrix offers comprehensive testing
services for the detection of abnormalities of genes at the DNA
level beyond what can be identified through traditional
technologies. The Company performs genetic testing utilizing
microarray, FISH, PCR and G-Band chromosome analyses. Additional
information about CombiMatrix is available at www.combimatrix.com
or by calling 1-800-710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
Tel (949) 753-0624
Investor Relations / Media Contact:
Rene Caron
Partner
Allen & Caron, Inc.
Tel (949) 474-4300
rene@allencaron.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2024 to Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Combimatrix Corp. (MM) (NASDAQ): 0 recent articles
More News Articles